Appendix XI
According to Schedule y the safety reports should be sent to regulatory authorities with in 15 days.Incase if the event experienced by the indian population Appendix XI should be submitted along with CIOMS form.
Data Elements for reporting serious adverse events occuring in a clinical trial
1. Patient Details
Initials & other relevant identifier (hospital/OPD record number etc.)*
Gender
Age and/or date of birth
Weight
Height
2. Suspected Drug(s)
Generic name of the drug*
Indication(s) for which suspect drug was prescribed or tested
Dosage form and strength
Daily dose and regimen (specify units - e.g., mg, ml, mg/kg)
Route of administration
Starting date and time of day
Stopping date and time, or duration of treatment
3. Other Treatment(s)
Provide the same information for concomitant drugs (including non prescription/OTC drugs) and non-drug therapies, as for the suspected drug(s).
4. Details of Suspected Adverse Drug Reaction(s)
Full description of reaction(s) including body site and severity, as well as the criterion (or criteria) for regarding the report as serious. In addition to a description of the reported signs and symptoms, whenever possible, describe a specific diagnosis for the reaction.*
Start date (and time) of onset of reaction
Stop date (and time) or duration of reaction
Dechallenge and rechallenge information
Setting (e.g., hospital, out-patient clinic, home, nursing home)
5. Outcome
Information on recovery and any sequelae; results of specific tests and/or treatment that may have been conducted
For a fatal outcome, cause of death and a comment on its possible relationship to the suspected reaction; Any post-mortem findings.
Other information: anything relevant to facilitate assessment of the case, such as medical history including allergy, drug or alcohol abuse; family history; findings from special investigations etc.
6. Details about the Investigator*
Name
Address
Telephone number
Profession (specialty)
Date of reporting the event to Licensing Authority:
Date of reporting the event to Ethics Committee overseeing the site:
Signature of the Investigator
Note: Information marked * must be provided.”
Saturday, September 18, 2010
Subscribe to:
Post Comments (Atom)
Blog patrol Free Blog counter widgets&Stats
Blog Archive
-
▼
2010
(77)
-
▼
September
(11)
- Question & answer By Dr. ARUN BHATT
- Registration of the Ethics committee with US Depa...
- Requirements For Filing Applications for Global Cl...
- An Expert Committee set up by Central Drugs Standa...
- Differences between Indian GCP and ICH GCP
- ICH GCP and Indian GCP
- FDA Warning letters
- Pharmacovigilance
- Medical Ethics
- concise guide to clinical Trails
- why Appendix XI submitted along with CIOMS to EC
-
▼
September
(11)
About Me
- ram
- Hyderabad, Andhra, India
- working as a clinical Research coordinator at yashoda Hospital,Somajiguda,Hyderabad
No comments:
Post a Comment